Latest filing published 26 Feb 2010 for Zivo Bioscience, Inc., €265.8M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Janet Crance: trading record in brief
All filings by Janet Crance on record concern Zivo Bioscience, Inc. The record holds 4 filings, for trades running from 20 May 2008 to 24 February 2010.
The open-market record is one-sided, with 4 purchases worth €8.8B and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2010: 1 purchase and no sales on the market.
Half of the purchases are above €132.9M and half below.
The record was last updated on 26 February 2010 with an open-market purchase (€265.8M) in Zivo Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Janet Crance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares@ US$6,000.00Common stockSEC:0001078782-10-000372:0Canonical exit: 25 May 2010 (T+90)
- 490,000 shares@ US$24,500.00Common stockSEC:0001078782-09-000914:0Canonical exit: 6 Sept 2009 (T+90)
- 455,000 shares@ US$0.05Common StockSEC:0001078782-09-000083:0Canonical exit: 28 Apr 2009 (T+90)
- 100,000 shares@ US$0.10COMMON STOCKSEC:0001078782-08-000763:0Canonical exit: 18 Aug 2008 (T+90)
4 of 4 declarations
